Investor Relations

Press Releases

Press Releases

Jul 30, 2020
Karuna Therapeutics to Present at Upcoming Investor Conferences
BOSTON --(BUSINESS WIRE)--Jul. 30, 2020-- Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders and
May 27, 2020
Karuna Therapeutics to Present Additional Data from the Phase 2 Clinical Trial of KarXT for the Treatment of Psychosis in Patients with Schizophrenia at the American Society of Clinical Psychopharmacology 2020 Annual Meeting
BOSTON --(BUSINESS WIRE)--May 27, 2020-- Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders and pain,
Displaying 1 - 10 of 14
Top